Mirus Bio
Brad Andrulonis, MBA has a diverse work experience spanning over several industries. Starting in 2008, they worked as an Account Manager/Intern at Aflac for three years. In 2011, they transitioned to a Sales/Marketing role at The Baltimore Sun Media Group for a brief period of five months. From 2012 to 2020, they served as a Key Account Manager at Quality Biological, Inc. In 2020, they joined Polyplus as a Sales Mid-Atlantic and continued in this role until June 2023. Currently, they are employed at Mirus Bio as an Account Manager for AMG South.
Brad Andrulonis has a Master of Business Administration (MBA) degree from Southern New Hampshire University, which they obtained from 2016 to 2017. Prior to that, they earned a Bachelor's degree in Marketing from Salisbury University and the Perdue School of Business from 2007 to 2011.
This person is not in any offices
Mirus Bio
1 followers
Mirus Bio Corporation, a life science company, discovers, develops, and commercializes nucleic acid based technologies and products. It provides transfection reagents, electroporation kits and solutions, DNA and RNA labeling reagents, in vivo delivery products, and accessories. The company offers its products through distributors in Argentina,Australia, Austria, Belgium, Bangladesh, Canada, Chile, the People's Republic of China, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Israel, Japan, Korea, Malaysia, the Netherlands, New Zealand, Norway, the Philippines, Portugal, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, the United Kingdom, the United States, and Vietnam. Mirus Bio Corporation was formerly known as Mirus Corporation. The company was founded in 1995 and is based in Madison, Wisconsin. As of September 30, 2008, Mirus Bio Corporation operates as a subsidiary of Roche Holding AG.